Submitted by reuters8361 in business
Pfizer <a href="https://www.reuters.com/markets/companies/PFE.N" target="_blank">(PFE.N)</a> on Tuesday said it will launch a cost-cutting program if its COVID-19 vaccine and antiviral treatment keep underperforming expectations in the coming months due to pl…